Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01552499 · ClinicalTrials.gov registry record · NA
Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
A NA study of Diabetic Foot Ulcer, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT01552499 is a NA study of Diabetic Foot Ulcer that has completed, run by MiMedx Group. The registered enrollment target is 25 participants, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01552499, a NA study of Diabetic Foot Ulcer, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the EpiFix human amniotic membrane is effective in the treatment of diabetic foot ulcers.
Conditions Studied
Interventions
- OTHER Standard of care
- OTHER Applications of EpiFix
Study Locations (1)
Virginia
- Professional Education and Research Institute - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01552499
The ClinicalTrials.gov registry entry for NCT01552499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (90% lower). The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT01552499 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT01552499 about?
NCT01552499 is a clinical study titled "Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers". The purpose of this study is to determine whether the EpiFix human amniotic membrane is effective in the treatment of diabetic foot ulcers.
What is the current status of trial NCT01552499?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2012-03. Estimated completion is 2012-08.
What conditions does trial NCT01552499 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT01552499?
The interventions under investigation include: Standard of care (OTHER), Applications of EpiFix (OTHER).
Who is sponsoring clinical trial NCT01552499?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01552499 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.